Fact CheckerSign in

NCT06941597Completed

Comparison of Two Gait Re-training Modalities During a Cardiac Rehabilitation Stay: Benefit of Orienteering Walking

Source: ClinicalTrials.gov · Last updated 24 Dec 2025

Brief summary (registry, in English)

Cardiovascular disease (CVD) is the leading cause of death in France for women and the second leading cause of death for men after cancer. They cause around 140,000 deaths every year, or almost 400 people every day throughout France. CVD also accounts for over a million hospital admissions a year, 160,000 of which are attributable to heart failure. At present, cardiovascular rehabilitation centres mainly use exercise training methods based on sessions on cycloergometers and active walking (walking on a track and/or treadmill). Convinced of the added value of Orienteering, we have included it in our routine treatment as part of our Cardiac Rehabilitation programme, in addition to sessions on cycloergometers and active walking since 2021. As there is little literature on the subject in our population of interest, the aim of this study is to provide evidence of the relevance of orienteering in the cardiac rehabilitation programme. We hypothesise that orienteering induces a similar cardiac response, amount of physical activity and perception of symptoms compared with an active walking session, while providing greater enjoyment of the activity.

Status (registry)
Completed
Study type
Observational
Enrollment
40 (actual)
First submitted
16 Apr 2025
Start date
28 Apr 2025
Primary completion date
5 Oct 2025
Lead sponsor
Fondation Ildys
NCT number
NCT06941597

What you commit to

  • Study type: Observational
  • Participants enrolled: 40
  • From 28 Apr 2025 to the primary completion date, 5 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnant or breast-feeding women
  • Persons under guardianship or trusteeship

Who the study is looking for

  • Patients with stabilised heart disease, coronary artery disease, heart failure, post-operative stay after cardiac surgery, congenital heart disease, patients at high cardiovascular risk and obliterative arteritis of the lower limbs;
  • Who have been informed and do not object to the study;
  • Over 18 years of age;
  • Participating in a cardiac rehabilitation programme;
  • With a walking distance of less than 3,600 metres;
  • Able to understand and comply with the requirements of the protocol.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondation ILDYS, Site de Ty Yann
Coordinator of this site? Confirm its status
BrestFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.